Coronavirus & Atopic Dermatitis Reporting Registry
EPI Health has graciously supported the COVID-19 News and Resource Center.
SECURE-AD (Surveillance Epidemiology of Corona Virus (COVID-19) Under Research Exclusion - Atopic Dermatitis) is a secure, online, de-identified international reporting registry for health care providers to report outcomes of COVID-19 in atopic dermatitis (AD) patients.
Clinicians worldwide are encouraged to report al …
EPI Health has graciously supported the COVID-19 News and Resource Center.
SECURE-AD (Surveillance Epidemiology of Corona Virus (COVID-19) Under Research Exclusion - Atopic Dermatitis) is a secure, online, de-identified international reporting registry for health care providers to report outcomes of COVID-19 in atopic dermatitis (AD) patients.
Clinicians worldwide are encouraged to report al … Continue reading "Coronavirus & Atopic Dermatitis Reporting Registry"
What is the most common cause of hypertension in this patient?
A. Autonomic Dysregulation
B. Optic Glioma
C. Renal Artery Stenosis
D. Medication induced
E. Medullary adrenal gland tumor
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. A product of SanovaWorks.
… 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference interviewed Dr. Adam Friedman, Professor, Interim Chair of Dermatology, and Residency Program Director at George Washington University, on some of the common misconceptions and controversies surrounding photoprotection.
With ample evidence today that shows that sunscreen both reduces the incidence of me … 
EPI Health has graciously supported the COVID-19 News and Resource Center.
USA TODAY and countless other media outlets have recently covered a dermatological phenomenon called COVID toes. Are COVID toes a true skin manifestation of COVID-19?
For an expert opinion, I consulted dermatologist Amy McMichael, MD, professor and chair of the department of dermatology, Wake Forest Baptist Medical Ce … 
Have you ever come across a patient with a skin cancer that you are not 100% sure should be treated with Mohs surgery or an alternative modality? Or a patient who comes back for a follow-up after skin cancer surgery with an undesirable scar and you wonder if you should have opted for a less invasive option? I certainly have. Some of these nagging questions were answered by a thoughtful, case-based … 